Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency

Clinical Endocrinology

Volumn 70, Issue 2, 2009, Pages 201-207

  Zhang, Hui Jie ^a   Yang, Jun ^a   Zhang, Man Na ^a   Zhang, Wei ^a   Liu, Jian Min ^a   Wang, Wei Qing ^a   Ning, Guang ^a   Li, Xiao Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 21A2; LUCIFERASE; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; STEROID 21 MONOOXYGENASE DEFICIENCY; TRANSCRIPTION INITIATION; VIRILIZATION;

ADRENAL HYPERPLASIA, CONGENITAL; CHINA; FEMALE; HETEROZYGOTE; HUMANS; MUTATION; PHENOTYPE; PROMOTER REGIONS, GENETIC; STEROID 21-HYDROXYLASE; VIRILISM; YOUNG ADULT;

EID: 58549084981     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03356.x     Document Type: Article

References (27)

1. White, P.C., New, M.I. Dupont, B. (1987) Congenital adrenal hyperplasia (2). New England Journal of Medicine, 316, 1580 1586.
2. White, P.C. New, M.I. (1992) Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 74, 6 11.
3. Speiser, P.W., Dupont, J., Zhu, D. et al. (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Investigation, 90, 584 595.
4. Krone, N., Braun, A., Roscher, A.A. et al. (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. Journal of Clinical Endocrinology and Metabolism, 85, 1059 1065.
5. Wilson, R.C., Mercado, A.B., Cheng, K.C. et al. (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. Journal of Clinical Endocrinology and Metabolism, 80, 2322 2329.
6. Billerbeck, A.E., Bachega, T.A., Frazatto, E.T. et al. (1999) A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 2870 2872.
7. Bachega, T.A., Billerbeck, A.E., Madureira, G. et al. (1998) Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 4416 4419.
8. Dolzan, V., Stopar-Obreza, M., Zerjav-Tansek, M. et al. (2003) Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease. European Journal of Endocrinology, 149, 137 144.
9. Araujo, R.S., Mendonca, B.B., Barbosa, A.S. et al. (2007) Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 92, 4028 4034.
10. Araujo, R.S., Billerbeck, A.E., Madureira, G. et al. (2005) Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clinical Endocrinology, 62, 132 136.
11. Huang, N., Pandey, A.V., Agrawal, V. et al. (2005) Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. American Journal of Human Genetics, 76, 729 749.
12. Lee, H.H., Won, G.S., Chao, H.T. et al. (2005) Novel missense mutations, GCC [Ala306]- > GTC [Val] and ACG [Thr318]- > CCG [Pro], in the CYP11B1 gene cause steroid 11beta-hydroxylase deficiency in the Chinese. Clinical Endocrinology, 62, 418 422.
13. Watanabe, N., Kitazume, M., Fujisawa, J. et al. (1993) A novel cAMP-dependent regulatory region including a sequence like the cAMP-responsive element, far upstream of the human CYP21A2 gene. European Journal of Biochemistry, 214, 521 531.
14. Wijesuriya, S.D., Zhang, G., Dardis, A. et al. (1999) Transcriptional regulatory elements of the human gene for cytochrome P450c21 (steroid 21-hydroxylase) lie within intron 35 of the linked C4B gene. Journal of Biological Chemistry, 274, 38097 38106.
15. Chin, K.K. Chang, S.F. (1998) The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction. Nucleic Acids Research, 26, 1959 1964.
16. Globerman, H., Amor, M., Parker, K.L. et al. (1988) Nonsense mutation causing steroid 21-hydroxylase deficiency. Journal of Clinical Investigation, 82, 139 144.
17. Kagawa, N. Waterman, M.R. (1990) cAMP-dependent transcription of the human CYP21B (P-450C21) gene requires a cis-regulatory element distinct from the consensus cAMP-regulatory element. Journal of Biological Chemistry, 265, 11299 11305.
18. Chang, S.F. Chung, B.C. (1995) Difference in transcriptional activity of two homologous CYP21A genes. Molecular Endocrinology, 9, 1330 1336.
19. Rice, D.A., Kronenberg, M.S., Mouw, A.R. et al. (1990) Multiple regulatory elements determine adrenocortical expression of steroid 21-hydroxylase. Journal of Biological Chemistry, 265, 8052 8058.
20. Bobba, A., Marra, E., Lattanzio, P. et al. (2000) Characterization of the CYP21 gene 5′ flanking region in patients affected by 21-OH deficiency. Human Mutation, 15, 481.
21. Kelly, S.N., McKenna, T.J. Young, L.S. (2004) Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal. Journal of Endocrinology, 181, 355 365.
22. Tee, M.K., Babalola, G.O., Aza-Blanc, P. et al. (1995) A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA: location of a cryptic CYP21 promoter element? Human Molecular Genetics, 4, 2109 2116.
23. Arlt, W., Walker, E.A., Draper, N. et al. (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet, 363, 2128 2135.
24. Sasaki, H., Kawano, O., Endo, K. et al. (2007) EGFRvIII mutation in lung cancer correlates with increased EGFR copy number. Oncology Reports, 17, 319 323.
25. White, P.C., Tusie-Luna, M.T., New, M.I. et al. (1994) Mutations in steroid 21-hydroxylase (CYP21). Human Mutation, 3, 373 378.
26. Jiddou, R.R., Wei, W.L., Sane, K.S. et al. (1999) Single-nucleotide polymorphisms in intron 2 of CYP21P: evidence for a higher rate of mutation at CpG dinucleotides in the functional steroid 21-hydroxylase gene and application to segregation analysis in congenital adrenal hyperplasia. Clinical Chemistry, 45, 625 629.
27. Lajic, S., Levo, A., Nikoshkov, A. et al. (1997) A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. Human Genetics, 99, 704 709.